Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease
- Resource Type
- Article
- Source
- In
Neurobiology of Aging May 2015 36(5):1792-1807 - Subject
- Language
- ISSN
- 0197-4580